Journal article
Authors list: Omwandho, COA; Gruessner, SEM; Roberts, TK; Tinneberg, HR
Publication year: 2004
Pages: 359-370
Journal: Clinical Chemistry and Laboratory Medicine
Volume number: 42
Issue number: 4
ISSN: 1434-6621
eISSN: 1437-4331
DOI Link: https://doi.org/10.1515/CCLM.2004.065
Publisher: De Gruyter
Abstract:
Recurrent pregnancy loss has been associated with autoimmune responses to membrane phospholipids and alloimmune reactions against paternally derived molecules on the trophoblast. The problem is psychologically and economically stressful as it undermines the capacity of some couples to reproduce and participate effectively in the daytoday economic activities. This article reviews the adoption of intravenous immunoglobulin as a form of therapy for the clinical management of recurrent pregnancy loss and of selected autoimmune disorders. Side effects, contraindications and safety of use are discussed.
Citation Styles
Harvard Citation style: Omwandho, C., Gruessner, S., Roberts, T. and Tinneberg, H. (2004) Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders, Clinical Chemistry and Laboratory Medicine, 42(4), pp. 359-370. https://doi.org/10.1515/CCLM.2004.065
APA Citation style: Omwandho, C., Gruessner, S., Roberts, T., & Tinneberg, H. (2004). Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders. Clinical Chemistry and Laboratory Medicine. 42(4), 359-370. https://doi.org/10.1515/CCLM.2004.065
Keywords
autoimmune disorders; GAMMA-GLOBULIN; GUILLAIN-BARRE-SYNDROME; IMMUNE GLOBULIN; INTRAVENOUS IMMUNOGLOBULIN; KAWASAKI-DISEASE; LUPUS NEPHRITIS; ORAL PREDNISONE; PLASMA-EXCHANGE; POSSIBLE MECHANISM; RANDOMIZED-TRIAL; recurrent pregnancy loss
